Literature DB >> 2881528

The use of psychostimulants in general psychiatry. A reconsideration.

R J Chiarello, J O Cole.   

Abstract

A half century after the introduction of amphetamine sulfate (benzedrine), there remains active interest in the use of the major psychostimulants (ie, methylphenidate hydrochloride and pemoline) for the treatment of psychiatric disorders. In the absence of any recent review of the literature on the clinical uses of psychostimulants, we assessed the existing data on the adult psychiatric indications for these agents. Generally, the existing studies are old and inadequate. However, there is some evidence to support the judicious use of psychostimulants in selected clinical instances of several adult psychiatric syndromes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881528     DOI: 10.1001/archpsyc.1987.01800150110013

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  14 in total

1.  Intractable depression in tertiary care.

Authors:  R H Gerner
Journal:  West J Med       Date:  1989-09

2.  d-Amphetamine-induced "floating limb" syndrome in young rhesus monkeys.

Authors:  E D Levin; P J Bushnell; C M Baysinger
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 3.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

Review 4.  Adjunctive therapy in patients with Alzheimer's disease. A practical approach.

Authors:  J Corey-Bloom; D Galasko
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

Review 5.  [Treatment of depression in the elderly. The use of psychostimulants].

Authors:  M Arcand; P Hottin
Journal:  Can Fam Physician       Date:  1993-11       Impact factor: 3.275

6.  Central Stimulant Treatment of Childhood Attention Deficit Hyperactivity Disorder : Issues and Recommendations from a US Perspective.

Authors:  D J Safer
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

Review 7.  Identifying patients at risk for, and treatment of major psychiatric complications of cancer.

Authors:  W Breitbart
Journal:  Support Care Cancer       Date:  1995-01       Impact factor: 3.603

Review 8.  Diagnostic and pharmacological approaches in Alzheimer's disease.

Authors:  C Hermann; R G Stern; M F Losonzcy; S Jaff; M Davidson
Journal:  Drugs Aging       Date:  1991-03       Impact factor: 3.923

Review 9.  'Designer drugs'. A problem in clinical toxicology.

Authors:  J F Buchanan; C R Brown
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jan-Dec

Review 10.  Recent advances in geriatric psychopharmacology.

Authors:  C A Naranjo; N Herrmann; N Mittmann; K E Bremner
Journal:  Drugs Aging       Date:  1995-09       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.